Sunday, September 24, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from Bayer AG.
Steering Committee Member Chair
Professor of Medicine
Director
Am. Heart Assoc. Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, Illinois, United States
Clinical Professor of Medicine
University of California
Irvine Medical Center
Irvine, California, United States
Professor of Medicine
Washington University School of Medicine
St. Louis, Missouri, United States
Nephrologist and Vascular Medicine Specialist
Princess Grace Hospital
Private Hemodialysis Centre
Monaco, Monaco
Coordinator
Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT)
Head of Complications Research
Steno Diabetes Center Copenhagen
Herlev, Denmark
Professor
Department of Clinical Medicine
University of Copenhagen
Copenhagen, Denmark
Department of Internal Medicine I (Cardiology)
University Hospital RWTH Aachen
Aachen, Germany
Steering Committee Chair
Has the following relevant financial relationships:
Consultant or advisor for: Alnylam; AstraZeneca; Bayer; Dia Medica Therapeutics; Horizon; Ionis; KBP Biosciences; Merck; Novo Nordisk; Quantum Genomics
Research funding from: Bayer
Has the following relevant financial relationships:
Consultant or advisor for: Abbott; AstraZeneca; Bayer; GlaxoSmithKline; Immuvent (former); Intuity (former); Janssen; Lilly/Boehringer Ingelheim; Novo Nordisk (former); Phathom Pharmaceuticals (former); RevHealth (former)
Speaker or member of speakers bureau for: AstraZeneca; Bayer; GlaxoSmithKline; Janssen; Lilly/Boehringer Ingelheim; Novo Nordisk (former)
Owns stock (publicly traded) in: Abbott
Has the following relevant financial relationships:
Consultant or advisor for: Bayer; Boehringer Ingelheim; Mannkind; Novo Nordisk
Research funding from: Beta Bionics; Novo Nordisk
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Bayer; Boehringer Ingelheim; CinCor; Idorsia; KBP Biosciences; Novartis; Novo Nordisk; Relypsa Inc., a Vifor Pharma Group Company; Sequana Medical; Servier; Vifor Fresenius Medical Care Renal Pharma
Speaker or member of speakers bureau for: Bayer; Novartis; Novo Nordisk; Vifor Pharma
Research funding from: Vifor Pharma
Contracted researcher for: Ablative Solutions; Janssen; Vascular Dynamics
Patent beneficiary of: CardioRenal (co-founder)
Stock options from: CardioRenal; G3P
Owns stock (privately owned) in: CardioRenal (co-founder)
Has the following relevant financial relationships:
Consultant or advisor for: Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Gilead; Novo Nordisk
Speaker or member of speakers bureau for: Eli Lilly; Sanofi
Research funding from: AstraZeneca; Novo Nordisk
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Bayer; Boehringer Ingelheim
Speaker or member of speakers bureau for: Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Lilly; Merck Sharp Dohme; Novo Nordisk; Novartis
